Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

Roche gets CE mark for Elecsys Dengue Ag test to diagnose dengue Pharma News

Roche gets CE mark for Elecsys Dengue Ag test to diagnose dengue

  • 02 November 2025
  • 4 hours from now

Roche appoints Nina Schwab-Hautzinger as Head of Group Communications Pharma News

Roche appoints Nina Schwab-Hautzinger as Head of Group Communications

  • 26 October 2025
  • 6 days ago

USFDA nod to Roche Gazyva/Gazyvaro for lupus nephritis Pharma News

USFDA nod to Roche Gazyva/Gazyvaro for lupus nephritis

  • 22 October 2025
  • 1 week ago

Natco Gets SC Nod to Launch Generic Risdiplam at 80% Lower Price, Roche Appeal Dismissed Pharma News

Natco Gets SC Nod to Launch Generic Risdiplam at 80% Lower Price, Roche Appeal Dismissed

  • 18 October 2025
  • 2 weeks ago

Roche Moves SC Against Delhi HC Nod to Natco's Rs 15,900 Generic Risdiplam for Spinal Atrophy State News

Roche Moves SC Against Delhi HC Nod to Natco's Rs 15,900 Generic Risdiplam for Spinal Atrophy

  • 16 October 2025
  • 2 weeks ago

Roche gets USFDA clearance for Elecsys pTau181 test for Alzheimer's disease Pharma News

Roche gets USFDA clearance for Elecsys pTau181 test for Alzheimer's disease

  • 15 October 2025
  • 2 weeks ago

Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy Pharma News

Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy

  • 11 October 2025
  • 3 weeks ago

Roche bags USFDA nod for Tecentriq plus lurbinectedin for extensive-stage small cell lung cancer Oncology

Roche bags USFDA nod for Tecentriq plus lurbinectedin for extensive-stage small cell lung cancer

  • 04 October 2025
  • 4 weeks ago

Roche subcutaneous formulation of Lunsumio recommended by CHMP for EU nod for follicular lymphoma Pharma News

Roche subcutaneous formulation of Lunsumio recommended by CHMP for EU nod for follicular lymphoma

  • 21 September 2025
  • 1 month ago

Roche to acquire 89bio for up to USD 3.5 billion Gastroenterology

Roche to acquire 89bio for up to USD 3.5 billion

  • 18 September 2025
  • 1 month ago

Recent News

Himachal notifies Resident doctor policy 2025

  • 02 November, 2025

Pfizer files lawsuit against Metsera, its Director...

  • 02 November, 2025

Health Ministry achieves 3 Guinness World Records...

  • 02 November, 2025

Roche gets CE mark for Elecsys Dengue Ag test to d...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.